AI for Biomaterials and Drug Design
Key Speakers (preliminary program)
Machine learning methods for the de-novo design of proteins and antibodiesPhilip M. Kim
Professor, Donnelly Centre for Cellular and Biomolecular Research, University of Toronto
Chemical Discovery and AI-Assisted Chemical SynthesisConnor Coley
Assistant Professor of Chemical Engineering, Massachusetts Institute of Technology
Combining machine learning with other computational methods for drug designGlenn Butterfoss
Senior Computational Biologist, ProteinQure
Advances in computational power coupled with big data analysis and innovations in machine learning, modeling and simulation approaches are enabling artificial intelligence to revolutionize the biomaterials and drug discovery and development process.
Submit your abstract and join researchers from around the world as we highlight the latest developments in this area.